BIOMAT Database Logo BIOMAT Database Logo

Recovery from mitomycin-induced pulmonary arterial hypertension. 2014

Liza Botros, and Geerten P Van Nieuw Amerongen, and Anton Vonk Noordegraaf, and Harm Jan Bogaard
1 VU University Medical Centre Amsterdam, The Netherlands.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077300 Bosentan A sulfonamide and pyrimidine derivative that acts as a dual endothelin receptor antagonist used to manage PULMONARY HYPERTENSION and SYSTEMIC SCLEROSIS. 4-t-Butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide,Bosentan Anhydrous,Bosentan Monohydrate,Ro 47-0203,Ro-47-0203,Tracleer,Ro 47 0203,Ro 470203
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001005 Anus Neoplasms Tumors or cancer of the ANAL CANAL. Anal Cancer,Cancer of Anus,Anal Neoplasms,Cancer of the Anus,Neoplasms, Anal,Neoplasms, Anus,Anal Cancers,Anal Neoplasm,Anus Cancer,Anus Cancers,Anus Neoplasm,Cancer, Anal,Cancers, Anal,Neoplasm, Anal,Neoplasm, Anus
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D016685 Mitomycin An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis. Mitomycin C,Ametycine,Mitocin-C,Mitomycin-C,Mutamycin,NSC-26980,Mitocin C,MitocinC,NSC 26980,NSC26980

Related Publications

Liza Botros, and Geerten P Van Nieuw Amerongen, and Anton Vonk Noordegraaf, and Harm Jan Bogaard
"Anagrelide-induced pulmonary arterial hypertension": a rare case of drug-induced pulmonary arterial hypertension.
January 2019, Pulmonary circulation,
Liza Botros, and Geerten P Van Nieuw Amerongen, and Anton Vonk Noordegraaf, and Harm Jan Bogaard
Drugs induced pulmonary arterial hypertension.
September 2013, Presse medicale (Paris, France : 1983),
Liza Botros, and Geerten P Van Nieuw Amerongen, and Anton Vonk Noordegraaf, and Harm Jan Bogaard
Exercise-induced pulmonary arterial hypertension.
November 2008, Circulation,
Liza Botros, and Geerten P Van Nieuw Amerongen, and Anton Vonk Noordegraaf, and Harm Jan Bogaard
Lorlatinib - Induced pulmonary arterial hypertension.
June 2018, Lung cancer (Amsterdam, Netherlands),
Liza Botros, and Geerten P Van Nieuw Amerongen, and Anton Vonk Noordegraaf, and Harm Jan Bogaard
Dasatinib-Induced Pulmonary Arterial Hypertension.
August 2020, American journal of therapeutics,
Liza Botros, and Geerten P Van Nieuw Amerongen, and Anton Vonk Noordegraaf, and Harm Jan Bogaard
Dasatinib-induced pulmonary arterial hypertension.
May 2018, British journal of clinical pharmacology,
Liza Botros, and Geerten P Van Nieuw Amerongen, and Anton Vonk Noordegraaf, and Harm Jan Bogaard
Scurvy-induced pulmonary arterial hypertension.
April 2023, BMJ case reports,
Liza Botros, and Geerten P Van Nieuw Amerongen, and Anton Vonk Noordegraaf, and Harm Jan Bogaard
Dasatinib-Induced Pulmonary Arterial Hypertension.
November 2019, The Canadian journal of cardiology,
Liza Botros, and Geerten P Van Nieuw Amerongen, and Anton Vonk Noordegraaf, and Harm Jan Bogaard
Implications of exercise-induced pulmonary arterial hypertension.
June 2011, Medicine and science in sports and exercise,
Liza Botros, and Geerten P Van Nieuw Amerongen, and Anton Vonk Noordegraaf, and Harm Jan Bogaard
Reversible Pulmonary Arterial Hypertension Induced by Dasatinib.
September 2022, Acta Cardiologica Sinica,
Copied contents to your clipboard!